A breast cancer drug, which could extend the lives of women by seven months, will be available on the NHS after the watchdog reversed its decision to reject the treatment. Around 100 women a year with advanced breast cancer will be able to try a new type of immunotherapy. The National Institute for Health and Care Excellence( Nice) overturned its draft rejection of Keytruda, also known as pembrolizumab, and has said women can take the drug in combination with chemotherapy.... The drug is for wo